H, A., MB, S., R, C., HE, J., R, D., E, G., & S, T. (2023). Therapeutic Drug Monitoring of Tacrolimus in Tunisian Renal Transplant Patients during the Tuberculosis Infection: A Retrospective, Observational, Single-centre Analysis. Current drug safety, 18(3), 340. https://doi.org/10.2174/1574886317666220525112713
Chicago Style (17th ed.) CitationH, Ammar, Sassi MB, Charfi R, Jebar HE, Daghfous R, Gaies E, and Trabelsi S. "Therapeutic Drug Monitoring of Tacrolimus in Tunisian Renal Transplant Patients During the Tuberculosis Infection: A Retrospective, Observational, Single-centre Analysis." Current Drug Safety 18, no. 3 (2023): 340. https://doi.org/10.2174/1574886317666220525112713.
MLA (9th ed.) CitationH, Ammar, et al. "Therapeutic Drug Monitoring of Tacrolimus in Tunisian Renal Transplant Patients During the Tuberculosis Infection: A Retrospective, Observational, Single-centre Analysis." Current Drug Safety, vol. 18, no. 3, 2023, p. 340, https://doi.org/10.2174/1574886317666220525112713.